These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 2162324
1. The selective augmentation by recombinant human tumour necrosis factor-alpha of neutrophil responses to pathogenic Escherichia coli. Steadman R, Petersen MM, Williams D, Matthews N, Williams JD. Immunology; 1990 May; 70(1):133-5. PubMed ID: 2162324 [Abstract] [Full Text] [Related]
2. Differential augmentation by recombinant human tumor necrosis factor-alpha of neutrophil responses to particulate zymosan and glucan. Steadman R, Petersen MM, Topley N, Williams D, Matthews N, Spur B, Williams JD. J Immunol; 1990 Apr 01; 144(7):2712-8. PubMed ID: 2156933 [Abstract] [Full Text] [Related]
3. Zymosan-induced leukotriene B4 generation by human neutrophils is augmented by rhTNF-alpha but not chemotactic peptide. Petersen M, Steadman R, Hallett MB, Matthews N, Williams JD. Immunology; 1990 May 01; 70(1):75-81. PubMed ID: 2162325 [Abstract] [Full Text] [Related]
4. Protein kinase C activation modulates tumour necrosis factor-alpha priming of human neutrophils for zymosan-induced leukotriene B4 release. Petersen MM, Steadman R, Williams JD. Immunology; 1992 Feb 01; 75(2):275-80. PubMed ID: 1312994 [Abstract] [Full Text] [Related]
5. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes. Stewart AG, Harris T, De Nichilo M, Lopez AF. Immunology; 1991 Feb 01; 72(2):206-12. PubMed ID: 1849872 [Abstract] [Full Text] [Related]
6. Tumour necrosis factor alpha augments the release of an endothelium-dependent vasoconstrictor from human polymorphonuclear leukocytes. Sobey CG, Dusting GJ, Stewart AG. J Cardiovasc Pharmacol; 1992 Feb 01; 20(5):813-9. PubMed ID: 1280746 [Abstract] [Full Text] [Related]
8. Human neutrophil responses to pathogenic Escherichia coli are receptor-specific and selectively augmented by recombinant human tumor necrosis factor-alpha. Steadman R, Matthews N, Lichodziejewska M, Williams JD. J Infect Dis; 1991 May 01; 163(5):1033-9. PubMed ID: 1673463 [Abstract] [Full Text] [Related]
9. Effect of endogenous nitric oxide on tumour necrosis factor-alpha-induced leukosequestration and IL-8 release in guinea-pigs airways in vivo. Kuo HP, Hwang KH, Lin HC, Wang CH, Lu LC. Br J Pharmacol; 1997 Sep 01; 122(1):103-11. PubMed ID: 9298535 [Abstract] [Full Text] [Related]
10. In vitro effect of recombinant human tumor necrosis factor-alpha on canine neutrophil apoptosis. Oguma K, Sano J, Kano R, Watari T, Hasegawa A. Res Vet Sci; 2006 Apr 01; 80(2):162-6. PubMed ID: 16040067 [Abstract] [Full Text] [Related]
11. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release. Conti P, Barbacane RC, Reale M, Panara MR, Placido FC, Mier JW, Castracane JM, Dempsey RA. Biotechnol Ther; 1993 Apr 01; 4(3-4):239-52. PubMed ID: 8292972 [Abstract] [Full Text] [Related]
17. The loss of recombinant human granulocyte colony-stimulating factor and recombinant human TNF-alpha priming effects on the superoxide-generating response in exudated neutrophils is associated with a decrease in their receptor affinities. Niwa M, Yousif AE, Kohno K, Kanamori Y, Matsuno M, Abe A, Uematsu T. J Immunol; 1996 Nov 01; 157(9):4147-53. PubMed ID: 8892651 [Abstract] [Full Text] [Related]
18. The functional role of 55- and 75-kDa tumour necrosis factor receptors in human polymorphonuclear cells in vitro. Abe Y, Osuka Y, Nakata T, Kashu Y, Kimura S. Cytokine; 1995 Jan 01; 7(1):39-49. PubMed ID: 7749065 [Abstract] [Full Text] [Related]